SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego-based Aethlon Medical Inc., a company developing targeted therapeutic devices to address infectious diseases and cancer, announced that its majority-owned subsidiary Exosome Sciences Inc. has entered into a research collaboration with Thomas Jefferson University.April 3, 2015 1:04 p.m. Share
Edico Genome Inc. announced Monday a faster analysis of a whole genome sequence.
La Jolla Pharmaceutical Co., a business developing therapies for life-threatening diseases, announced that Dr. Lakhmir Chawla will be joining the company as chief medical officer, effective July 1.
Quidel Corp. reported strong financial results for the first quarter of 2015 with revenue up 31 percent, according to a recent earnings statement.
Psychiatric Centers at San Diego announced the appointments of Dr. Dennis Ordas as president and Leslie Randolph as chief executive officer.
BIOTECH: Rapid Results in the OR Should Reduce Re-Excision Rate
A device now being used at Sharp Memorial Hospital is helping surgeons more thoroughly remove cancerous tissue during breast cancer surgery, reducing the need for follow-up procedures and providing a better chance for patients to recover.
BIOTECH: Huge Data Sets to Get Rapid and Cost-Effective Analysis
Edico Genome Inc., a La Jolla-based tech startup, announced that it’s collaborating with Intel Corp. to speed up next-generation genome sequencing (NGS) data analysis.
San Diego-based Ligand Pharmaceuticals Inc. announced the appointment of Melanie Herman as interim chief financial officer, effective May 21.
ResMed Inc., a company that makes medical devices for sleep-related disorders, reported net income of about $91 million on net revenue of $422.5 million for the third quarter that ended March 31.
San Diego-based biotechnology firm Illumina Inc. posted a strong first quarter in 2015, reporting a 28 percent growth in revenue year over year.
Edico Genome Inc., a La Jolla-based tech startup, announced Tuesday that it’s collaborating with Intel Corp. to speed up next-generation sequencing data analysis.
GlycoRegImmune Inc. (GRI Bio), a biotech developing treatments for inflammatory disease, recently raised $4.38 million in equity financing, according to a recent regulatory filing.
DJO Global Inc., a medical device company in San Diego, announced Monday the financial results for its public reporting subsidiary, DJO Finance LLC, for the 2015 first quarter.
La Mesa-based Regen BioPharma Inc. announced that it added three internationally renowned cancer stem cell experts to its scientific advisory board.
Trovagene Inc., a cell-free molecular diagnostic company, announced that recent clinical data showed its urine-based Precision Cancer Monitoring platform outperformed traditional tissue biopsy for the detection and monitoring of specific mutations in metastatic lung cancer patients.
MediciNova, Inc., a biopharmaceutical company, announced that it has received Fast Track designation from the U.S. Food and Drug Administration for MN-001 (tipelukast) for the treatment of patients with nonalcoholic steatohepatitis (NASH) with fibrosis.